8. Cardamom
The queen of spices — 1,8-cineole, metabolic syndrome, and the Daneshi-Maskooni RCTs.
Cardamom in 1 minute
What does it provide? 1,8-cineole (eucalyptol), α-terpinyl acetate, and limonene — digestion-supporting, antioxidant, anti-inflammatory, metabolic-syndrome-attenuating.
How much? In the kitchen, 2–6 whole pods (≈ 0.5–2 g) daily. In clinical RCTs, 3 g of green cardamom powder/day in 8–10-week T2D trials (Daneshi-Maskooni).
When to avoid? Active gallstones, high-dose supplement in pregnancy, clinical supplement alongside anticoagulants, infants in concentrated form.
Cardamom is native to the rainforests of South India and Sri Lanka, appearing in Indian Ayurveda as "elaichi" — a key element of classic "rasayana" (rejuvenating) medicines. It reached the Greco-Roman world in the time of Hippocrates and Theophrastus — in Pliny it appears as "cardamomum," and was one of the most expensive Roman imported spices alongside pepper and cinnamon. Scandinavian cuisine received it through the Vikings' 9th–10th-century Constantinople trade ties — this is the origin of the cardamom ratio in today's Swedish, Danish, and Norwegian pastries.
After the 16th century, Guatemala became the world's largest cardamom exporter — German coffee planter Oscar Majus Kloeffer brought Indian seeds there in 1914 (Guatemala became the leading producer from the second half of the 20th century, from the 1970s). Today, Guatemala's exports far exceed Indian production. Modern phytochemical analysis (1960s) identified the main bioactives (1,8-cineole, α-terpinyl acetate), and 2010s controlled clinical trials (Aghasi 2018, Daneshi-Maskooni 2019) led by Iranian research groups found a moderate but reproducible metabolic effect in T2D, NAFLD, and metabolic syndrome.[2284] The FEMA-GRAS (Flavor and Extract Manufacturers Association — Generally Recognized As Safe) status also supports cardamom essential oil's safe culinary and food-industry use.[2285]
Scientific Background
The pod of cardamom (green cardamom, Elettaria cardamomum) contains 4–6% essential oil, in which 1,8-cineole (25–45%), α-terpinyl acetate (25–35%), limonene, sabinene, and linalool are the main components. 1,8-Cineole (eucalyptol) has well-documented bronchodilator, mucolytic, and antimicrobial effects — in synthetic form (Soledum) it is officially licensed for chronic bronchitis.[2286]
The metabolic evidence comes from the Iranian RCT trove of recent years. In NAFLD and T2D RCTs of 2018–2019, Daneshi-Maskooni demonstrated that 3 g/day of green cardamom powder over 8–10 weeks significantly reduced fasting glucose, HbA1c, inflammation markers (TNF-α, IL-6), and liver enzymes (ALT, AST).[2281][2282] Aghasi 2018 described similar improvement in metabolic syndrome.[2283] The effect is medium-sized but reproducible.
Its antimicrobial spectrum is broad in vitro — particularly effective against oral microbiome pathogens (S. mutans), which is the scientific basis of traditional "cardamom breath-freshening" use.[2287]
At the microbiome level, small preclinical studies showed enrichment of Bifidobacterium and Lactobacillus by cardamom's polyphenol fraction; human data are limited.
Due to its choleretic (bile-flow-stimulating) effect, to be avoided in active gallstones — similar to turmeric and artichoke.
- + Cinnamon, clove, cumin, pepper: classic Indian garam masala synergy.
- + Hot tea (chai): essential oil dissolves well, classic Indian breakfast pattern.
- + Hot milk, oatmeal: classic Scandinavian pastry aroma.
- + Honey, maple syrup: flavor harmony, classic Swedish "kardemummabullar" (cardamom buns).
- + Polyphenol-rich matrix (coffee, cacao, green tea): flavor harmony + antioxidant synergy.
- + Fiber-rich diet: metabolic synergy in T2D prevention.
- Anticoagulants + high-dose extract: theoretical additive risk.
- HIV protease inhibitors (1,8-cineole may be a CYP inducer): theoretical drug-level reduction.
- Concentrated essential oil on empty stomach: GI irritation.
- Sustained high-temperature cooking: essential oil evaporates — add toward the end of cooking.
- Concentrated 1,8-cineole oil in infant's mouth: respiratory spasm danger.
- Diabetic medications + high-dose supplement chronically: hypoglycemia monitoring advised.
- Active gallstones, cholangitis: choleretic.
- Infant, small child (< 2 years) topical/inhalation 1,8-cineole: respiratory depression danger.
- Pregnancy high-dose supplement: uterine-stimulating potential in animal experiments.
- Active gastric ulcer: concentrated essential oil irritates.
- Asthma flare: 1,8-cineole is normally a bronchodilator, but in sensitive individuals paradoxical bronchospasm possible.
- Severe liver disease: to be avoided as a high-dose supplement.
- Anticoagulant therapy: medical supervision.
- Zingiberaceae allergy: rare cross-reaction.
Daily serving
2–6 whole pods (≈ 0.5–2 g) daily; for clinical purposes, 1–3 g of powder for NAFLD/T2D support.
Preparation pattern
- Crack the whole pods with weight (flat side of a knife) — seeds are released.
- Whole pod: in tea, in vegetable dish, in rice cooking water → 5–10 min cooking.
- Seeds: ground for baking dough, for garam masala.
- Remove the whole pods before serving.
Classic patterns
Masala chai: black tea + milk + cardamom + ginger + cinnamon + clove + pepper + sugar.
Swedish kardemummabullar: yeasted dough + freshly ground cardamom + butter + sugar.
Arab qahwa: finely ground coffee + crushed cardamom pod + clove + water, slow simmer.
Indian biryani: rice + cardamom + bay leaf + clove + pepper + meat + saffron.
Storage and what to avoid
Storage: whole pod 2 years airtight, in a dark place; ground powder shows significant aroma loss after 6 weeks.
What not to do: don't cook long at high heat (1,8-cineole evaporates), don't give concentrated essential oil to infants as inhalation, don't combine high-dose supplements with active gallstones.
References
[2281] Daneshi-Maskooni M et al. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in NAFLD: a double-blind randomized clinical trial2019;19(1):59. BMC Complement Altern Med. Link
BACKGROUND: Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green cardamom (GC) on serum glucose indices, lipids, and irisin level among overweight or obese NAFLD patients. METHODS: The place of participant recruitment was the polyclinic of the National Iranian Oil Company (NIOC) central hospital in Tehran. Based on the ultrasonography and eligibility criteria, 87 participants were randomly divided into two groups as cardamom (n = 43) or placebo (n = 44). The supplementation was two 500 mg capsules 3 times/day with meals for 3 months. Serum irisin, fasting blood sugar (FBS), insulin (FBI), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c) were measured.
[2282] Aghasi M et al. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus 2018;99(8):3933–3940. J Sci Food Agric. 2018. Link
Randomised, double-blind, placebo-controlled clinical trial in 83 overweight/obese patients with type 2 diabetes who received 3 g/day of green cardamom or placebo for 10 weeks. Compared with control, the cardamom group showed significant decreases in HbA1c, insulin, HOMA-IR and triglycerides, and an increase in serum SIRT1. The results indicate a beneficial effect of green cardamom on glycemic indices and lipids in type 2 diabetes.
[2283] Verma SK et al. Effect of green cardamom on blood pressure, lipid profile, oxidative stress and fibrinolytic activity in newly diagnosed Stage I hypertensive patients 2009;46(6):503–506. Indian J Biochem Biophys. 2009.
Study (Indian J Biochem Biophys, 2009) on the effect of green cardamom on blood pressure, lipid profile, oxidative stress and fibrinolytic activity in newly diagnosed Stage I hypertensive patients.
[2284] Padmakumari Amma KP et al. Phytochemical and pharmacological evaluation of small cardamom — review 2010;4(8):134–141. Pharmacogn Rev. 2010.
Phytochemical and pharmacological review (Pharmacogn Rev, 2010) of small cardamom.
[2285] FEMA. Cardamom oil — GRAS evaluation.
FEMA GRAS evaluation of cardamom oil.
[2286] Juergens UR. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases 2014;64(12):638–646. Drug Res. 2014. Link
Review of the anti-inflammatory properties of the monoterpene 1,8-cineole (eucalyptol) and the evidence for its use as co-medication in inflammatory airway diseases (asthma, COPD). The author summarizes the anti-inflammatory and antioxidant mode of action of 1,8-cineole, along with its mucolytic and spasmolytic effects on the airways. More recent clinical trials suggest a beneficial role of 1,8-cineole in preventing COPD exacerbations and improving asthma control.
[2287] Souissi M et al. Anti-bacterial activity of cardamom volatile oil against Streptococcus mutans 2020. Arch Oral Biol. 2020.
Study (Arch Oral Biol, 2020) on the antibacterial activity of cardamom volatile oil against Streptococcus mutans.